Company
Last deal
$100.M
Amount
Series B
Stage
06.01.2022
Date
2
all rounds
$130.M
Total amount
General
About Company
Virtue Diagnostics offers clinical solutions for infectious disease, cancer, maternal & fetal health, and chronic disease.
Industry
Sector :
Subsector :
Keywords :
Also Known As
Virtue, Yikun Bio, 颐坤生物
founded date
01.01.2019
Number of employees
Company Type
For Profit
Last funding type
Series B
IPO status
Private